Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant
- PMID: 35367284
- PMCID: PMC8968180
- DOI: 10.1016/j.virusres.2022.198765
Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant
Abstract
Background: Emergence of new variant of SARS-CoV-2, namely omicron, has posed a global concern because of its high rate of transmissibility and mutations in its genome. Researchers worldwide are trying to understand the evolution and emergence of such variants to understand the mutational cascade events.
Methods: We have considered all omicron genomes (n = 302 genomes) available till 2nd December 2021 in the public repository of GISAID along with representatives of variants of concern (VOC), i.e., alpha, beta, gamma, delta, and omicron; variant of interest (VOI) mu and lambda; and variant under monitoring (VUM). Whole genome-based phylogeny and mutational analysis were performed to understand the evolution of SARS CoV-2 leading to emergence of omicron variant.
Results: Whole genome-based phylogeny depicted two phylogroups (PG-I and PG-II) forming variant specific clades except for gamma and VUM GH. Mutational analysis detected 18,261 mutations in the omicron variant, majority of which were non-synonymous mutations in spike (A67, T547K, D614G, H655Y, N679K, P681H, D796Y, N856K, Q954H), followed by RNA dependent RNA polymerase (rdrp) (A1892T, I189V, P314L, K38R, T492I, V57V), ORF6 (M19M) and nucleocapsid protein (RG203KR).
Conclusion: Delta and omicron have evolutionary diverged into distinct phylogroups and do not share a common ancestry. While, omicron shares common ancestry with VOI lambda and its evolution is mainly derived by the non-synonymous mutations.
Keywords: NSP, non-structural protein; SARS-CoV-2, COVID-19, genome-wide, evolution, variants, VOC, VOI, VUM, SNP, mutation, non-synonymous, silent mutation, spike, RNA dependent RNA polymerase, NSP, UTR: Abbreviations: VOC, variant of concern; UTR, untranslated region; VOI, variant of interest; VUM, variant under monitoring; rdrp, RNA dependent RNA polymerase.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
The author declares no competing interest.
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2: A pan India study.Virus Res. 2022 Jan 15;308:198642. doi: 10.1016/j.virusres.2021.198642. Epub 2021 Nov 22. Virus Res. 2022. PMID: 34822953 Free PMC article.
-
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.Microbiol Spectr. 2022 Apr 27;10(2):e0273221. doi: 10.1128/spectrum.02732-21. Epub 2022 Mar 30. Microbiol Spectr. 2022. PMID: 35352942 Free PMC article.
-
Rapidly identifying new coronavirus mutations of potential concern in the Omicron variant using an unsupervised learning strategy.Sci Rep. 2022 Nov 9;12(1):19089. doi: 10.1038/s41598-022-23342-2. Sci Rep. 2022. PMID: 36352021 Free PMC article.
-
Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.J Med Virol. 2023 Jan;95(1):e28366. doi: 10.1002/jmv.28366. J Med Virol. 2023. PMID: 36458547 Free PMC article. Review.
-
JN.1 variant in enduring COVID-19 pandemic: is it a variety of interest (VoI) or variety of concern (VoC)?Horm Mol Biol Clin Investig. 2024 Apr 17;45(2):49-53. doi: 10.1515/hmbci-2023-0088. eCollection 2024 Jun 1. Horm Mol Biol Clin Investig. 2024. PMID: 38622986 Review.
Cited by
-
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?J Virol. 2022 Mar 23;96(6):e0207721. doi: 10.1128/jvi.02077-21. Epub 2022 Mar 23. J Virol. 2022. PMID: 35225672 Free PMC article. Review.
-
SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19.Diagnostics (Basel). 2023 Feb 2;13(3):559. doi: 10.3390/diagnostics13030559. Diagnostics (Basel). 2023. PMID: 36766664 Free PMC article. Review.
-
Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants.Front Immunol. 2024 Feb 23;15:1339660. doi: 10.3389/fimmu.2024.1339660. eCollection 2024. Front Immunol. 2024. PMID: 38464527 Free PMC article. Review.
-
Predicting COVID-19 disease severity from SARS-CoV-2 spike protein sequence by mixed effects machine learning.Comput Biol Med. 2022 Oct;149:105969. doi: 10.1016/j.compbiomed.2022.105969. Epub 2022 Aug 17. Comput Biol Med. 2022. PMID: 36041271 Free PMC article.
-
Rapid Antigen Diagnostics as Frontline Testing in the COVID-19 Pandemic.Small Sci. 2022 Aug;2(8):2200009. doi: 10.1002/smsc.202200009. Epub 2022 Jul 5. Small Sci. 2022. PMID: 35942171 Free PMC article.
References
-
- Andreadakis Z., Kumar A., Román R.G., Tollefsen S., Saville M., Mayhew S. The COVID-19 vaccine development landscape. Nat. Rev. Drug Discov. 2020;19(5):305–306. - PubMed
-
- Bansal K., Kumar S., Patil P.B. bioRxiv; 2021. Codon usage pattern reveals SARS-CoV-2 as a monomorphic pathogen of hybrid origin with role of silent mutations in rapid evolutionary success. 2020.2010.2012.335521. - DOI
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous